Get the Stockscreener App
3.73
1.91%
0.07
Avalon Globocare Corp stock is traded at $3.73, with a volume of 34,914.
It is up +1.91% in the last 24 hours and up +9.06% over the past month.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
See More
Previous Close:
$3.66
Open:
$3.46
24h Volume:
34,914
Relative Volume:
0.02
Market Cap:
$4.08M
Revenue:
$1.31M
Net Income/Loss:
$-14.73M
P/E Ratio:
-0.1867
EPS:
-19.98
Net Cash Flow:
$-4.69M
1W Performance:
+11.34%
1M Performance:
+9.06%
6M Performance:
-39.42%
1Y Performance:
-41.49%
1-Day Range:
$3.3591
$3.73
1-Week Range:
$3.3591
$3.81
52-Week Range:
$2.11
$21.60
Avalon Globocare Corp Stock (ALBT) Company Profile
Name
Avalon Globocare Corp
Sector
Industry
Phone
732-780-4400
Address
4400 ROUTE 9, FREEHOLD
Compare ALBT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALBT
Avalon Globocare Corp
|
3.73 | 4.08M | 1.31M | -14.73M | -4.69M | -19.98 |
|
CBRE
Cbre Group Inc
|
140.94 | 43.13B | 34.31B | 958.00M | 913.00M | 3.11 |
|
CSGP
Costar Group Inc
|
74.16 | 30.40B | 2.67B | 175.40M | -61.90M | 0.44 |
|
BEKE
Ke Holdings Inc Adr
|
16.90 | 20.25B | 10.78B | 579.98M | 881.47M | 0.493 |
|
JLL
Jones Lang Lasalle Inc
|
270.97 | 12.86B | 22.50B | 478.00M | 411.90M | 9.89 |
|
FSV
Firstservice Corp
|
182.63 | 8.24B | 4.93B | 108.16M | 203.45M | 2.40 |
Avalon Globocare Corp Stock (ALBT) Latest News
Head to Head Analysis: Sangamo Therapeutics (NASDAQ:SGMO) versus Avalon GloboCare (NASDAQ:ALBT) - Defense World
Avalon GloboCare announces preferred stock exchange and amendment By Investing.com - Investing.com Australia
Avalon GloboCare announces preferred stock exchange and amendment - Investing.com India
Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific and Clinical Advisory Board - Marketscreener.com
Avalon GloboCare Corp. (NASDAQ:ALBT) Sees Significant Increase in Short Interest - Defense World
Avalon GloboCare Enters into Securities Purchase Agreement with InvestorOn December 19, 2024, Avalon GloboCare Corp. (NASDAQ: ALBT) announced that it had entered into a securities purchase agreement with an accredited investor, York Sun Investme - Defense World
Avalon GloboCare announces $7M preferred stock sale By Investing.com - Investing.com Nigeria
Avalon GloboCare announces $7M preferred stock sale - Investing.com India
Avalon GloboCare (NASDAQ:ALBT) vs. Krystal Biotech (NASDAQ:KRYS) Head-To-Head Analysis - Defense World
3 Penny Stocks to Watch Now, 12/10/24 - TipRanks
Why Interpublic Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Avalon GloboCare Regains Nasdaq Compliance - Investing.com
Avalon GloboCare Achieves Nasdaq Compliance with Strong Governance - TipRanks
Avalon GloboCare Regains Compliance with Nasdaq Continued Listing Requirements - GlobeNewswire
Avalon GloboCare Regains Nasdaq Compliance, Reaffirms Growth Strategy | ALBT Stock News - StockTitan
Avalon launches ‘BrAce for Impact’ affiliate marketing program - TipRanks
Avalon GloboCare Launches “BrAce for Impact" Affiliate Marketing Program for the KetoAir Breathalyzer Device - GlobeNewswire
Avalon GloboCare Launches AI-Powered KetoAir™ Affiliate Program for Ketosis Monitoring | ALBT Stock News - StockTitan
Critical Review: Innate Pharma (NASDAQ:IPHA) vs. Avalon GloboCare (NASDAQ:ALBT) - Defense World
Avalon GloboCare Third Quarter 2024 Earnings: US$1.82 loss per share (vs US$2.06 loss in 3Q 2023) - Yahoo Finance
Avalon GloboCare Corp. (ALBT) Quarterly 10-Q Report - Quartz
U.S. Stock market: Zoomcar Holdings (+192.21%), Avalon GloboCare (+56.73%), and Vimeo (+40.85%) experience significant gains during mid day trading - Business Upturn
U.S. Stock market: Zoomcar Holdings up 87.10%, Avalon GloboCare jumps 57.14%, Vimeo rises 44.07% among top gainers - Business Upturn
U.S. Stock market: Verrica Pharmaceuticals and Marqeta stocks plummet over 37%, while Avalon GloboCare soars 75% in volatile market trend - Business Upturn
Avalon Globocare stock hits 52-week low at $2.4 amid market challenges - Investing.com Canada
Avalon Globocare stock hits 52-week low at $2.4 amid market challenges By Investing.com - Investing.com South Africa
Avalon GloboCare faces Nasdaq delisting after rule breach - Investing.com India
Avalon GloboCare Appoints Dr. Charles Cavo to Scientific Advisory Board Support for KetoAir Sales - Defense World
Avalon GloboCare faces Nasdaq delisting after rule breach By Investing.com - Investing.com South Africa
Avalon appoints Cavto to Scientific Advisory Board - TipRanks
Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir Sales - GlobeNewswire
Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Update - Defense World
Avalon GloboCare Announces Reverse Stock Split and Decrease in Shares By Investing.com - Investing.com South Africa
Avalon GloboCare Announces Reverse Stock Split and Decrease in Shares - Investing.com
Avalon Globocare stock hits 52-week high at $3.45 By Investing.com - Investing.com South Africa
Avalon Globocare stock hits 52-week high at $3.45 - Investing.com
Avalon GloboCare Stock Set to Reverse Split on Monday, October 28th (NASDAQ:ALBT) - Defense World
Avalon GloboCare Collaborates for Cannabis Breathalyzer Development - TipRanks
Avalon, enters MOU with Qi Diagnostics - TipRanks
Avalon GloboCare and Qi Diagnostics Enter into Memorandum - GlobeNewswire
Avalon GloboCare and Qi Diagnostics Enter into Memorandum of Understanding for Proposed Co-Development of Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving - StockTitan
EXCLUSIVE: Avalon GloboCare Inks MoU With Qi Diagnostics For Proposed Co-Development Of Real-Time Cannabis Breathalyzer - Yahoo Finance
Avalon Globocare Corp Stock (ALBT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.76%
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):